Publications by authors named "Terrance Ocheltree"

Claim this Profile
A
An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.
David M Fleischer, Sharon Chinthrajah, Amy M Scurlock, Dianne E Campbell, Todd D Green, Terrance Ocheltree

Allergy Asthma Proc· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergy.
David M Fleischer, Jonathan M Spergel, Edwin H Kim, Dianne E Campbell, Todd D Green, Terrance Ocheltree

Allergy Asthma Proc· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adhesion Evaluation of AG200-15: An Investigational Transdermal Contraceptive Delivery System.
Terrance Ocheltree, Janet Wittes, Jessica Case, Michael Tuley, Irina Krause

Adv Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.
Glenn A Van Buskirk, Satish Asotra, Christopher Balducci, Prabir Basu, Gerald DiDonato, Terrance Ocheltree

AAPS PharmSciTech· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passive transdermal systems whitepaper incorporating current chemistry, manufacturing and controls (CMC) development principles.
Glenn A Van Buskirk, Daniel Arsulowicz, Prabir Basu, Lawrence Block, Bing Cai, Terrance Ocheltree

AAPS PharmSciTech· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folotyn (pralatrexate injection) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma: U.S. Food and Drug Administration drug approval summary.
Shakun M Malik, Ke Liu, Xu Qiang, Rajeshwari Sridhara, Shenghui Tang, Terrance Ocheltree

Clin Cancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.
Michael Brave, Ann Farrell, Sue Ching Lin, Terrance Ocheltree, Sarah Pope Miksinski

Oncology· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis